IL-1β has been linked with poor prognosis in breast cancer [251] and plays a critical role in the recruitment and maturation of adaptive T cell-mediated immunity including CD4+ and CD8+ T cells [252] and myeloid cells [68]. This evidence concerns the gene CD8A and breast carcinoma.